Tazorac 0.5 MG in 1 GM Topical Gel

RxCUI: 212437
RxNorm name: Tazorac 0.5 MG in 1 GM Topical Gel
Display name: Tazorac 0.5 MG in 1 GM Topical Gel
Full name: Tazorac 0.5 MG in 1 GM Topical Gel
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:57

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Tazorac	TAZAROTENE	Almirall, LLC	4e4e4b81-420e-4492-8a74-80b692a80057	2025-11-13	Warnings, Adverse reactions	Exact identifier rxcui: 212437

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
4e4e4b81-420e-4492-8a74-80b692a80057	Tazorac 0.5 MG in 1 GM Topical Gel	SY	4	These highlights do not include all the information needed to use TAZORAC ® Gel safely and effectively. See full prescribing information for TAZORAC ® Gel. TAZORAC ® (tazarotene) gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 1997	20251113
4e4e4b81-420e-4492-8a74-80b692a80057	TAZORAC 0.05 % Topical Gel	PSN	4	These highlights do not include all the information needed to use TAZORAC ® Gel safely and effectively. See full prescribing information for TAZORAC ® Gel. TAZORAC ® (tazarotene) gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 1997	20251113
4e4e4b81-420e-4492-8a74-80b692a80057	tazarotene 0.0005 MG/MG Topical Gel [Tazorac]	SBD	4	These highlights do not include all the information needed to use TAZORAC ® Gel safely and effectively. See full prescribing information for TAZORAC ® Gel. TAZORAC ® (tazarotene) gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 1997	20251113
4e4e4b81-420e-4492-8a74-80b692a80057	Tazorac 0.05 % Topical Gel	SY	4	These highlights do not include all the information needed to use TAZORAC ® Gel safely and effectively. See full prescribing information for TAZORAC ® Gel. TAZORAC ® (tazarotene) gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 1997	20251113
4e4e4b81-420e-4492-8a74-80b692a80057	Tazorac 0.0005 MG/MG Topical Gel	SY	4	These highlights do not include all the information needed to use TAZORAC ® Gel safely and effectively. See full prescribing information for TAZORAC ® Gel. TAZORAC ® (tazarotene) gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 1997	20251113